Predictive and prognostic role of fragile histidine triad (FHIT) and P53 gene inactivaton in non-small-cell lung cancer (NSCLC) patients treated with platinum-analogue regimen

被引：0
|
作者：
Cortinovis, D.
Bajetta, E.
Sozzi, G.
Mariani, L.
Fabbri, A.
Livio, A.
Roz, L.
Andriani, F.
Perego, P.
Zilembo, N.
Formisano, B.
Bidoli, P.
机构：
[1] Ist Nazl Studio & Cura Tumori, Med Oncol Unit 2, I-20133 Milan, Italy
[2] Ist Nazl Studio & Cura Tumori, Dept Expt Oncol, I-20133 Milan, Italy
[3] Ist Nazl Studio & Cura Tumori, Dept Med Stat, I-20133 Milan, Italy
[4] Ist Nazl Studio & Cura Tumori, Anat Pathol Unit, I-20133 Milan, Italy
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：XI19 / XI19
页数：1
相关论文
共 50 条
  • [41] Prognostic relevance of altered pRb and p53 protein expression in surgically treated non-small cell lung cancer patients
    Dworakowska, D
    Jassem, E
    Jassem, J
    Wiedorn, KH
    Boltze, C
    Karmolinski, A
    Dworakowski, R
    Skokowski, J
    Jaskiewicz, K
    Bosse, A
    Czestochowska, E
    ONCOLOGY, 2004, 67 (01) : 60 - 66
  • [42] P21WAF1/CIP1 and p53 protein expression in non-small-cell lung cancer (NSCLC)
    Dworakowska, D
    Jassem, E
    Jassem, J
    Boltze, C
    Wiedorn, KH
    Karmolinski, A
    Dworakowski, R
    Lapinski, M
    Tomaszewski, D
    Skokowski, J
    Jaskiewicz, K
    Czestochowska, E
    LUNG CANCER, 2004, 45 : S31 - S31
  • [43] Prognostic model in advanced non-small cell lung cancer (NSCLC) patients treated with platinum-based chemotherapy
    Radosavljevic, D. Z.
    Gavrilovic, D.
    Golubicic, I.
    Jelic, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [44] RAS AND P53 EXPRESSION IN NON-SMALL-CELL LUNG-CANCER PATIENTS - P53 OVER-EXPRESSION CORRELATES WITH A POOR PROGNOSIS
    PAPADAKIS, E
    MALLIRI, A
    LINARDOPOULOS, S
    KARAIOSSIFIDI, H
    FIELD, JK
    SPANDIDOS, DA
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1992, 1 (04) : 403 - 413
  • [45] The prognostic and predictive role of hyponatremia in patients with advanced non-small cell lung cancer (NSCLC) with bone metastases
    Rinaldi, S.
    Santoni, M.
    Leoni, G.
    Fiordoliva, I.
    Marcantognini, G.
    Meletani, T.
    Armento, G.
    Santini, D.
    Newsom-Davis, T.
    Tiberi, M.
    Morgese, F.
    Torniai, M.
    Bower, M.
    Berardi, Rossana
    SUPPORTIVE CARE IN CANCER, 2019, 27 (04) : 1255 - 1261
  • [46] Prognostic value of serum p53 antibodies in patients with resected non-small cell lung cancer
    Laudanski, J
    Burzykowski, T
    Niklinska, W
    Chyczewski, L
    Furman, M
    Niklinski, J
    LUNG CANCER, 1998, 22 (03) : 191 - 200
  • [47] The prognostic and predictive role of hyponatremia in patients with advanced non-small cell lung cancer (NSCLC) with bone metastases
    S. Rinaldi
    M. Santoni
    G. Leoni
    I. Fiordoliva
    G. Marcantognini
    T. Meletani
    G. Armento
    D. Santini
    T. Newsom-Davis
    M. Tiberi
    F. Morgese
    M. Torniai
    M. Bower
    Rossana Berardi
    Supportive Care in Cancer, 2019, 27 : 1255 - 1261
  • [48] Arg72Pro P53 gene polymorphism:: Clinical relevance and relation with P53 mutations in non-small cell lung cancer (NSCLC) patients.
    Jassem, J
    Szymanowska, A
    Jassem, E
    Borg, A
    Holm, K
    Dziadziuszko, R
    Rzyman, W
    Kobierska-Gulida, G
    Limon, J
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 655S - 655S
  • [49] Prognostic factors in oligometastatic non-small-cell lung cancer (OM-NSCLC) patients treated with ablative therapy.
    Antonio Mendez, Juan
    Benjamin, Domingo
    Lorente, David
    Escoin, Corina
    Salvador, Carmen
    Navarro, Edwin
    Melian, Marcos
    Mancheno, Nuria
    Gomez-Codina, Jose
    Juan Vidal, Oscar
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [50] Adenoviral-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small cell lung cancer (NSCLC)
    Nemunaitis, J
    Swisher, SG
    Roth, JA
    Merritt, J
    CANCER GENE THERAPY, 1998, 5 (06) : S32 - S33
12345